Skip to main content
. 2026 Feb 18;27(4):1949. doi: 10.3390/ijms27041949
AML Acute myeloid leukemia
AUC Area under the curve
CA19-9 Carbohydrate Antigen 19-9
CACNA1d Calcium voltage-gated channel subunit alpha1 D
CEA Carcinoembryonic Antigen
CLL Chronic lymphocytic leukemia
C-MYC MYC proto-oncogene, bHLH transcription factor
CRC Colorectal cancer
CT Computed Tomography
DFS Disease-free survival
EEF1A2 Eukaryotic translation elongation factor 1 alpha 2
ESCC Esophageal squamous cell carcinoma
EVs Extracellular vesicles
FOXK1 Forkhead box K1
FUBP1 Far upstream element binding protein 1
HCC Hepatocellular carcinoma
LATS2 Large Tumor Suppressor Kinase 2
LGALS1 Galectin 1
LNA Locked nucleic acid
LSCC Laryngeal squamous cell carcinoma
MDM2 MDM2 proto-oncogene
miRNA microRNA
MM Multiple myeloma
mRNA Messenger RNA
NSCLC Non-small cell lung cancer
OS Overall survival
PBMCs Peripheral blood mononuclear cells
PDX Patient-derived xenograft
PDXO Patient-derived xenograft organoid
PFS Progression-free survival
pre-tRNAs Precursors tRNAs
qRT-PCR quantitative reverse-transcription PCR
RBM17 RNA binding motif protein 17
RCC Renal cell carcinoma
RG4 RNA G-quadruplex
RSP Prognostic risk score
sncRNAs Small non-coding RNAs
TCL1 T-Cell leukemia/lymphoma 1
tRNAs Transfer RNAs
tsRNAs Transfer RNA-derived small RNAs
UTR Untranslated region
YBX-1 Y-box binding protein 1